Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TP53 | P04637 | 1/20 | 0.57 |
| ▸ | TSHR | P16473 | 1/20 | 0.57 |
| ▸ | PLA2G4B | P0C869 | 6/20 | 0.56 |
| ▸ | RARB | P10826 | 3/20 | 0.53 |
| ▸ | MLNR | O43193 | 1/20 | 0.51 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.51 |
| ▸ | ESR1 | P03372 | 1/20 | 0.51 |
| ▸ | NR3C1 | P04150 | 1/20 | 0.51 |
| ▸ | PGR | P06401 | 1/20 | 0.51 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.51 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.51 |
| ▸ | ADRB1 | P08588 | 1/20 | 0.51 |
| ▸ | HTR1A | P08908 | 1/20 | 0.51 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.51 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.51 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.51 |
| ▸ | DRD2 | P14416 | 1/20 | 0.51 |
| ▸ | ADRA2B | P18089 | 1/20 | 0.51 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.51 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Cetrimonium SCHEMBL22396363 | 0.89 | TP53 (0.60) | TP53TSHRPLA2G4BRARBPLA2G4A | |
| SCHEMBL123687 | 0.88 | TP53 (0.76) | TP53TSHRPLA2G4BRARBMLNR | |
| SCHEMBL26983159 | 0.86 | TP53 (0.71) | TP53TSHRPLA2G4BRARBPLA2G4A | |
| Silver SCHEMBL9664694 | 0.86 | TP53 (0.71) | TP53TSHRPLA2G4BRARBPLA2G4A | |
| SCHEMBL28544196 | 0.86 | TP53 (0.71) | TP53TSHRPLA2G4BRARBPLA2G4A | |
| Silver SCHEMBL11321084 | 0.86 | TP53 (0.71) | TP53TSHRPLA2G4BRARBPLA2G4A | |
| SCHEMBL11135789 | 0.85 | RARB (0.78) | TP53TSHRPLA2G4BRARBPLA2G4A | |
| Silver SCHEMBL11423363 | 0.82 | RARB (0.73) | TP53TSHRPLA2G4BRARBPLA2G4A | |
| SCHEMBL11052789 | 0.81 | TP53 (0.62) | TP53TSHRPLA2G4BRARBPLA2G4A | |
| SCHEMBL7546522 | 0.81 | THRA (0.51) | RARBALDH1A1THRATHRB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1198 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4748905-A1 | LIQUID-CRYSTALLINE MEDIUM | Merck Patent GmbH (DE) | 2026-05-27 | — | — | EP | disclosed |
| CN-122080952-A | Liquid-crystalline medium | — | 2026-05-26 | — | — | CN | disclosed |
| US-12624290-B2 | Method for reducing white flicker | MERCK PATENT GMBH (DE) | 2026-05-12 | — | — | US | disclosed |
| US-12618007-B2 | Liquid-crystalline medium | MERCK PATENT GMBH (DE) | 2026-05-05 | — | — | US | disclosed |
| EP-4428214-B1 | LIQUID-CRYSTALLINE MEDIUM | MERCK PATENT GMBH (DE) | 2026-03-04 | — | — | EP | disclosed |
| EP-4428213-B1 | LIQUID-CRYSTALLINE MEDIUM | MERCK PATENT GMBH (DE) | 2026-03-04 | — | — | EP | disclosed |
| EP-4702104-A1 | LIQUID-CRYSTAL MEDIUM COMPRISING POLYMERIZABLE COMPOUND | Merck Patent GmbH (DE) | 2026-03-04 | — | — | EP | disclosed |
| US-12552991-B2 | Liquid-crystalline medium | MERCK PATENT GMBH (DE) | 2026-02-17 | — | — | US | disclosed |
| EP-4680691-A1 | LIQUID-CRYSTAL MEDIUM | Merck Patent GmbH (DE) | 2026-01-21 | — | — | EP | disclosed |
| US-12516245-B2 | Liquid-crystalline medium | MERCK PATENT GMBH (DE) | 2026-01-06 | — | — | US | disclosed |
| EP-0126949-A2 | Fluorine-containing pyrimidine derivatives | MERCK PATENT GmbH (DE) | 1984-12-05 | — | — | EP | disclosed |
| EP-0125563-A2 | Bicyclohexyl ethanes | MERCK PATENT GmbH (DE) | 1984-11-21 | — | — | EP | disclosed |
| US-4478740-A | Benzonitriles | MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) | 1984-10-23 | — | — | US | disclosed |
| EP-0117476-A1 | Tetrahydropyranes | MERCK PATENT GmbH (DE) | 1984-09-05 | — | — | EP | disclosed |
| EP-0107759-A2 | Cyclohexane derivatives and their use as components for liquid crystals | MERCK PATENT GmbH (DE) | 1984-05-09 | — | — | EP | disclosed |
| EP-0104327-A2 | Use of cyclic derivatives as components of liquid cristals | MERCK PATENT GmbH (DE) | 1984-04-04 | — | — | EP | disclosed |
| EP-0095626-A2 | Piperidine derivatives | MERCK PATENT GmbH (DE) | 1983-12-07 | — | — | EP | disclosed |
| EP-0094487-A1 | Hydroterphenyls, their preparation and their use in dielectric liquid crystal material | MERCK PATENT GmbH (DE) | 1983-11-23 | — | — | EP | disclosed |
| EP-0087056-A1 | Benzonitriles | MERCK PATENT GmbH (DE) | 1983-08-31 | — | — | EP | disclosed |
| US-3953491-A | ELECTROOPTICS | MERCK PATENT GESELLSCHAFT MIT BESCHRAENKTER HAFTUNG (DT) | 1976-04-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12552991-B2 | Liquid-crystalline medium | FES, VIM, INHA | TP53 263/4885TSHR 221/4885PLA2G4B 2935/4885 |
| US-12618007-B2 | Liquid-crystalline medium | SOST, NES, VIM | TP53 891/4885TSHR 174/4885PLA2G4B 2038/4885 |
| US-12624290-B2 | Method for reducing white flicker | HCN4, HCN2, HCN3 | TP53 4522/4885TSHR 2060/4885PLA2G4B 2201/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.